- Home
- XENE vs MTG Comparison
XENE vs MTG Comparison
Compare XENE & MTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XENE | MTG |
|---|---|---|
| Founded | 1996 | 1957 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.4B |
| IPO Year | 2014 | 2008 |
Fundamental Metrics
Financial Performance| Metric | XENE | MTG |
|---|---|---|
| Price | $55.81 | $27.00 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | ★ $68.55 | $28.50 |
| AVG Volume (30 Days) | 1.5M | ★ 1.8M |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | N/A | ★ 8.65 |
| EPS | N/A | ★ 0.76 |
| Revenue | $311,000.00 | ★ $1,213,636,000.00 |
| Revenue This Year | N/A | $2.50 |
| Revenue Next Year | $2,496.48 | $1.77 |
| P/E Ratio | ★ N/A | $34.86 |
| Revenue Growth | N/A | ★ 0.49 |
| 52 Week Low | $30.00 | $24.69 |
| 52 Week High | $62.91 | $29.97 |
Technical Indicators
Market Signals| Indicator | XENE | MTG |
|---|---|---|
| Relative Strength Index (RSI) | 60.01 | 63.56 |
| Support Level | $52.40 | $25.57 |
| Resistance Level | $56.66 | $27.14 |
| Average True Range (ATR) | 1.72 | 0.44 |
| MACD | 0.46 | 0.19 |
| Stochastic Oscillator | 86.26 | 90.61 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About MTG MGIC Investment Corporation
MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection account for close to the majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia, and New York.